The association between circulating endothelial progenitor cells and outcome in different subtypes of acute ischemic stroke

Clinica Chimica Acta

Volumn 427, Issue , 2014, Pages 6-10

  Tsai, Nai Wen ^a   Hung, Shu Hua ^b   Huang, Chi Ren ^a   Chang, Hsueh Wen ^c   Chang, Wen Neng ^a   Lee, Lian Hui ^a   Wang, Hung Chen ^a   Lin, Yu Jun ^a,c   Lin, Wei Che ^a   Cheng, Ben Chung ^a,c   Chiang, Yi Fang ^a   Su, Yu Jih ^a,c   Tsai, Tong Rong ^b   Lu, Cheng Hsien ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Acute ischemic stroke; Endothelial progenitor cells; Large vessel disease; Outcome; Small vessel disease

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CD34 SELECTION; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIRCULATING ENDOTHELIAL PROGENITOR CELL; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIFFUSION WEIGHTED IMAGING; DYSLIPIDEMIA; ENDOTHELIAL PROGENITOR CELL; ERYTHROCYTE COUNT; FEMALE; HEART STROKE VOLUME; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE COUNT; ACUTE DISEASE; ADOLESCENT; AGED; BLOOD; CLASSIFICATION; ENDOTHELIUM CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; STEM CELL; STROKE; VERY ELDERLY; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COHORT STUDIES; ENDOTHELIAL CELLS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; STEM CELLS; STROKE; YOUNG ADULT;

EID: 84885235302     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.09.029     Document Type: Article

References (37)

1. Hurtado O., Pradillo J.M., Alonso-Escolano D., et al. Neurorepair versus neuroprotection in stroke. Cerebrovasc Dis 2006, 21(Suppl. 2):54-63.
2. Graham S.H., Chen J. Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab 2001, 21:99-109.
3. Sairanen T., Carpen O., Karjalainen-Lindsberg M.L., et al. Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke 2001, 32:1750-1758.
4. Wei L., Erinjeri J.P., Rovainen C.M., Woolsey T.A. Collateral growth and angiogenesis around cortical stroke. Stroke 2001, 32:2179-2184.
5. Asahara T., Masuda H., Takahashi T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
6. Urbich C., Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95:343-353.
7. Hill J.M., Zalos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600.
8. Shantsila E., Watson T., Lip G.Y. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 2007, 49:741-752.
9. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-E7.
10. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005, 111:2981-2987.
11. Bakogiannis C., Tousoulis D., Androulakis E., et al. Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes. Curr Med Chem 2012, 19:2597-2604.
12. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007.
13. Taguchi A., Matsuyama T., Moriwaki H., et al. Circulating CD34-positive cells provide an index of cerebrovascular function. Circulation 2004, 109:2972-2975.
14. Yip H.K., Chang L.T., Chang W.N., et al. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke. Stroke 2008, 39:69-74.
15. Sobrino T., Hurtado O., Moro M.A., et al. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 2007, 38:2759-2764.
16. Adams H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
17. Goldstein L.B., Adams R., Alberts M.J., et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke 2006, 37:1583-1633.
18. Sacco R.L., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006, 37:577-617.
19. Sulter G., Steen C., De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 1999, 30:1538-1541.
20. Ghani U., Shuaib A., Salam A., et al. Endothelial progenitor cells during cerebrovascular disease. Stroke 2005, 36:151-153.
21. Jung K.H., Roh J.K. Circulating endothelial progenitor cells in cerebrovascular disease. J Clin Neurol 2008, 4:139-147.
22. Jung K.H., Chu K., Lee S.T., et al. Identification of neuronal outgrowth cells from peripheral blood of stroke patients. Ann Neurol 2008, 63:312-322.
23. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
24. Shantsila E., Watson T., Tse H.F., Lip G.Y. New insights on endothelial progenitor cell subpopulations and their angiogenic properties. J Am Coll Cardiol 2008, 51:669-671.
25. Lammie G.A., Brannan F., Slattery J., Warlow C. Nonhypertensive cerebral small-vessel disease. An autopsy study. Stroke 1997, 28:2222-2229.
26. Rothwell P.M. Atherothrombosis and ischaemic stroke. BMJ 2007, 334:379-380.
27. Di Carlo A., Lamassa M., Baldereschi M., et al. Risk factors and outcome of subtypes of ischemic stroke. Data from a multicenter multinational hospital-based registry. The European Community Stroke Project. J Neurol Sci 2006, 244:143-150.
28. Numaguchi Y., Sone T., Okumura K., et al. The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation 2006, 114:I114-I119.
29. Lev E.I., Kleiman N.S., Birnbaum Y., Harris D., Korbling M., Estrov Z. Circulating endothelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction. J Vasc Res 2005, 42:408-414.
30. Fadini G.P., Miorin M., Facco M., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005, 45:1449-1457.
31. Heiss C., Keymel S., Niesler U., Ziemann J., Kelm M., Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005, 45:1441-1448.
32. Vasa M., Fichtlscherer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001, 103:2885-2890.
33. Taguchi A., Soma T., Tanaka H., et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004, 114:330-338.
34. Zhang Z.G., Zhang L., Jiang Q., Chopp M. Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse. Circ Res 2002, 90:284-288.
35. Assmus B., Urbich C., Aicher A., et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 2003, 92:1049-1055.
36. Llevadot J., Murasawa S., Kureishi Y., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001, 108:399-405.
37. Bahlmann F.H., de Groot K., Mueller O., Hertel B., Haller H., Fliser D. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005, 45:526-529.